Clinical Trial Update: Universal CAR-T Cell Therapy for MM [NA]

View source ↗

Summary

A clinical trial is recruiting for a universal CAR-T cell therapy to treat multiple myeloma, including relapsed and refractory disease. The sponsor is Bioray La…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Universal CAR-T Cell Therapy

Snippet

Sponsor: Bioray Laboratories | Conditions: Multiple Myeloma, Multiple Myeloma in Relapse | NA | Status: RECRUITING